If not addressed, stomach paralysis may lead to malnutrition, dehydration, and blood sugar complications
Formulated with five novel, next-gen strains, Metabolic Daily uses the same powerful strains of Pendulums flagship product, Glucose Control , but at a dose that benefits metabolic health at a lower price
In 2025, the company reported a +6.03% YoY revenue growth, supported by its key therapies: Darzalex ($14.35B) continues to lead in multiple myeloma with strong global demand, Stelara ($6.07B) remains a major contributor despite upcoming patent pressures, and Tremfya ($5.15B) is gaining traction in immunology with expanding use across indications
Pre-clinical evaluation of a modified cyclodextrin-based nanoparticle for intestinal delivery of liraglutide
The sudden shift in eating patternsboth reduced portion sizes and changed food preferencesdisrupts the balance of bacteria that normally regulate digestion
SEP-479 oral small-molecule agonist of the parathyroid hormone 1 receptor (PTH1R) aimed at treating hypoparathyroidism Recent Highlights: In May 2025, Septerna signed an exclusive global collaboration with Novo Nordisk worth up to $2.2B to co-develop oral small molecule GLP-1, GIP, and glucagon receptor agonists
